Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver.
Pimsiri SripongpunChaitong ChuruangsukChalermrat BunchorntavakulPublished in: Journal of clinical and translational hepatology (2022)
Nonalcoholic fatty liver disease (NAFLD) is emerging globally, while no therapeutic medication has been approved as an effective treatment to date, lifestyle intervention through dietary modification and physical exercise plays a critical role in NAFLD management. In terms of dietary modification, Mediterranean diet is the most studied dietary pattern and is recommended in many guidelines, however, it may not be feasible and affordable for many patients. Recently, a ketogenic diet and intermittent fasting have gained public attention and have been studied in the role of weight management. This article reviews specifically whether these trendy dietary patterns have an effect on NAFLD outcomes regarding intrahepatic fat content, fibrosis, and liver enzymes, the scientific rationales behind these particular dietary patterns, as well as the safety concerns in some certain patient groups.
Keyphrases
- weight loss
- physical activity
- end stage renal disease
- healthcare
- blood glucose
- ejection fraction
- insulin resistance
- randomized controlled trial
- newly diagnosed
- high intensity
- chronic kidney disease
- body mass index
- cardiovascular disease
- mental health
- metabolic syndrome
- prognostic factors
- fatty acid
- case report
- emergency department
- systematic review
- clinical practice
- weight gain
- patient reported outcomes
- combination therapy
- glycemic control
- meta analyses